Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Abstract 4305: Germline structural variants shape prostate cancer clinical and molecular evolution

Cancer Res (2023) 83 (7_Supplement): 4305.

https://doi.org/10.1158/1538-7445.AM2023-4305

Published: 04 April 2023

View article titled, Abstract 4305: Germline structural variants shape prostate cancer clinical and molecular evolution

Journal Articles

Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors

James R. Hawley, Stanley Zhou, Christopher Arlidge, Giacomo Grillo, Ken J. Kron, Rupert Hugh-White, Theodorus H. van der Kwast, Michael Fraser, Paul C. Boutros, Robert G. Bristow, Mathieu Lupien

Cancer Res (2021) 81 (23): 5833–5848.

https://doi.org/10.1158/0008-5472.CAN-21-2056

Published: 01 December 2021

View article titled, Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors

Includes: Supplementary data

Journal Articles

Abstract SY37-01: Genomic instability and hypoxia as co-drivers of prostate cancer aggression

Robert G. Bristow

Cancer Res (2021) 81 (13_Supplement): SY37-01.

https://doi.org/10.1158/1538-7445.AM2021-SY37-01

Published: 01 July 2021

View article titled, Abstract SY37-01: Genomic instability and hypoxia as co-drivers of prostate cancer aggression

Journal Articles

Abstract 3810: Persistence of smoking signature 4 in the non-small cell lung cancer genome

Pantelis A. Nicola, Shereen Rafee, George Burghel, Andrew Wallace, Helene Schlecht, Eleanor Baker, Katie Baker, Lynsey Priest, Mathew Carter, Sharzad Moghadam, Jane Rogan, Robert G. Bristow, William Newman, Fiona H. Blackhall, Colin Lindsay

Cancer Res (2020) 80 (16_Supplement): 3810.

https://doi.org/10.1158/1538-7445.AM2020-3810

Published: 15 August 2020

View article titled, Abstract 3810: Persistence of smoking signature 4 in the non-small cell lung cancer genome

Journal Articles

Abstract 1763: Tumor mutational burden, mutational signatures and copy number variation in lung cancer driven by the Ras-Raf-MEK-ERK pathway

Pantelis A. Nicola, George Burghel, Andrew Wallace, Helene Schlecht, Eleanor Baker, Katie Baker, Lynsey Priest, Mathew Carter, Sharzad Moghadam, Jane Rogan, Robert G. Bristow, William Newman, Fiona Blackhall, Colin R. Lindsay

Cancer Res (2019) 79 (13_Supplement): 1763.

https://doi.org/10.1158/1538-7445.AM2019-1763

Published: 01 July 2019

View article titled, Abstract 1763: Tumor mutational burden, mutational signatures and copy number variation in lung cancer driven by the Ras-Raf-MEK-ERK pathway

Journal Articles

Abstract B100: High-risk pathologic and genomic features of BRCA2-mutant prostate cancer

Laura H. Porter, Mitchell G. Lawrence, Carmel Pezaro, Heather Thorne, Dragan Ilic, Melissa Papargiris, Michael Fraser, Julie Livingstone, Declan G. Murphy, Mark Frydenberg, Damien Bolton, Daniel Moon, David Clouston, Theo van der Kwast, Paul C. Boutros, Robert G. Bristow, Renea A. Taylor, Gail P. Risbridger

Cancer Res (2018) 78 (16_Supplement): B100.

https://doi.org/10.1158/1538-7445.PRCA2017-B100

Published: 14 August 2018

View article titled, Abstract B100: High-risk pathologic and genomic features of BRCA2-mutant prostate cancer

Journal Articles

Abstract NG06: The clinico-genomics of localized, non-indolent prostate cancer: the CPC-GENE experience

Michael E. Fraser, Theodorus van der Kwast, Robert G. Bristow, Michael E. Fraser

Cancer Res (2018) 78 (13_Supplement): NG06.

https://doi.org/10.1158/1538-7445.AM2018-NG06

Published: 01 July 2018

View article titled, Abstract NG06: The clinico-genomics of localized, non-indolent prostate cancer: the CPC-GENE experience

Journal Articles

Abstract 2432: The genomic consequences of tumor hypoxia in human cancers

Vinayak Bhandari, Shadrielle M. Espiritu, Lydia Y. Liu, Emilie Lalonde, Takafumi N. Yamaguchi, Lawrence E. Heisler, Julie Livingstone, Vincent Huang, Yu-Jia Shiah, Veronica Y. Sabelnykova, Fouad Yousif, Melvin L. Chua, Michael Fraser, Theodorus van der Kwast, Paul C. Boutros, Robert G. Bristow

Cancer Res (2018) 78 (13_Supplement): 2432.

https://doi.org/10.1158/1538-7445.AM2018-2432

Published: 01 July 2018

View article titled, Abstract 2432: The genomic consequences of tumor hypoxia in human cancers

Journal Articles

Abstract 5860: Genomic architecture of prostate cancer at recurrence following radiotherapy

Melvin L.K. Chua, Erle Holgersen, Veronica Sabelnykova, Adriana Salcedo, Alice Meng, Michael Fraser, Theodorus van der Kwast, Paul C. Boutros, Robert G. Bristow

Cancer Res (2017) 77 (13_Supplement): 5860.

https://doi.org/10.1158/1538-7445.AM2017-5860

Published: 01 July 2017

View article titled, Abstract 5860: Genomic architecture of prostate cancer at recurrence following radiotherapy

Journal Articles

Abstract 98: The somatic mutational landscape of the mitochondrial genome in prostate cancer: evaluation of clinical impact

Julia F. Hopkins, Veronica Y. Sabelnykova, John Watson, Lawrence E. Heisler, Junyan Zhang, Michael Fraser, Theodorus van der Kwast, Robert G. Bristow, Paul C. Boutros

Cancer Res (2016) 76 (14_Supplement): 98.

https://doi.org/10.1158/1538-7445.AM2016-98

Published: 15 July 2016

View article titled, Abstract 98: The somatic mutational landscape of the mitochondrial genome in prostate cancer: evaluation of clinical impact

Journal Articles

Abstract 745: Hybrid bioactive nanoparticles for modulating prostate tumor microenvironment and enhancing radiation therapy

Mohammad Ali Amini, Azhar Z. Abbasi, Claudia R. Gordijo1, Ping Cai, Andrew M. Rauth, Robert G. Bristow, Xiao Yu Wu

Cancer Res (2016) 76 (14_Supplement): 745.

https://doi.org/10.1158/1538-7445.AM2016-745

Published: 15 July 2016

View article titled, Abstract 745: Hybrid bioactive nanoparticles for modulating prostate tumor microenvironment and enhancing radiation therapy

Journal Articles

Abstract 2214: Dynamic transcriptome analysis of DNA damage pathways under hypoxia

Winnie W. Lo, Gaetano Zafarana, Robert G. Bristow

Cancer Res (2015) 75 (15_Supplement): 2214.

https://doi.org/10.1158/1538-7445.AM2015-2214

Published: 01 August 2015

View article titled, Abstract 2214: Dynamic transcriptome analysis of DNA damage pathways under hypoxia

Journal Articles

miRNA-95 Mediates Radioresistance in Tumors by Targeting the Sphingolipid Phosphatase SGPP1

Xiaoyong Huang, Samira Taeb, Sahar Jahangiri, Urban Emmenegger, Elisa Tran, Jeff Bruce, Aruz Mesci, Elina Korpela, Danny Vesprini, C. Shun Wong, Robert G. Bristow, Fei-Fei Liu, Stanley K. Liu

Cancer Res (2013) 73 (23): 6972–6986.

https://doi.org/10.1158/0008-5472.CAN-13-1657

Published: 01 December 2013

View article titled, miRNA-95 Mediates Radioresistance in Tumors by Targeting the Sphingolipid Phosphatase SGPP1

Includes: Supplementary data

Journal Articles

Imatinib Radiosensitizes Bladder Cancer by Targeting Homologous Recombination

Boling Qiao, Martin Kerr, Blaz Groselj, Mark T.W. Teo, Margaret A. Knowles, Robert G. Bristow, Roger M. Phillips, Anne E. Kiltie

Cancer Res (2013) 73 (5): 1611–1620.

https://doi.org/10.1158/0008-5472.CAN-12-1170

Published: 03 March 2013

View article titled, Imatinib Radiosensitizes Bladder Cancer by Targeting Homologous Recombination

Includes: Supplementary data

Journal Articles

Abstract 3184: Whole genome sequencing of low-input fresh frozen prostate cancer biopsies

Cancer Res (2012) 72 (8_Supplement): 3184.

https://doi.org/10.1158/1538-7445.AM2012-3184

Published: 15 April 2012

View article titled, Abstract 3184: Whole genome sequencing of low-input fresh frozen prostate cancer biopsies

Journal Articles

Abstract 3916: PML nuclear bodies are juxtaposed to DNA-DSBs following IR-induced DNA damage

Kenneth Chor Kin Tse, Shane M. Harding, Gaetano Zafarana, Kashif Ahmed, Graham Dellaire, David Bazett-Jones, Robert G. Bristow

Cancer Res (2011) 71 (8_Supplement): 3916.

https://doi.org/10.1158/1538-7445.AM2011-3916

Published: 15 April 2011

View article titled, Abstract 3916: PML nuclear bodies are juxtaposed to DNA-DSBs following IR-induced DNA damage

Journal Articles

Tumor Cell Kill by c-MYC Depletion: Role of MYC-Regulated Genes that Control DNA Double-Strand Break Repair

Kaisa R. Luoto, Alice X. Meng, Amanda R. Wasylishen, Helen Zhao, Carla L. Coackley, Linda Z. Penn, Robert G. Bristow

Cancer Res (2010) 70 (21): 8748–8759.

https://doi.org/10.1158/0008-5472.CAN-10-0944

Published: 31 October 2010

View article titled, Tumor Cell Kill by c-MYC Depletion: Role of MYC-Regulated Genes that Control DNA Double-Strand Break Repair

Includes: Supplementary data

Journal Articles

Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment

Norman Chan, Isabel M. Pires, Zuzana Bencokova, Carla Coackley, Kaisa R. Luoto, Nirmal Bhogal, Minalini Lakshman, Ponnari Gottipati, F. Javier Oliver, Thomas Helleday, Ester M. Hammond, Robert G. Bristow

Cancer Res (2010) 70 (20): 8045–8054.

https://doi.org/10.1158/0008-5472.CAN-10-2352

Published: 13 October 2010

View article titled, Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment

Includes: Supplementary data

Journal Articles

MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer

Ananya Choudhury, Louisa D. Nelson, Mark T.W. Teo, Sameer Chilka, Selina Bhattarai, Colin F. Johnston, Faye Elliott, Johanna Lowery, Claire F. Taylor, Michael Churchman, Johanne Bentley, Margaret A. Knowles, Patricia Harnden, Robert G. Bristow, D. Timothy Bishop, Anne E. Kiltie

Cancer Res (2010) 70 (18): 7017–7026.

https://doi.org/10.1158/0008-5472.CAN-10-1202

Published: 14 September 2010

View article titled, MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer

Includes: Supplementary data

Journal Articles

Abstract 3932: Loss of PTEN sensitizes cells to DNA damaging agents in a RAD51-independent manner

Michael E. Fraser, Helen Zhao, Cecilia Lundin, Andrew Evans, Thomas Helleday, Robert G. Bristow

Cancer Res (2010) 70 (8_Supplement): 3932.

https://doi.org/10.1158/1538-7445.AM10-3932

Published: 15 April 2010

View article titled, Abstract 3932: Loss of PTEN sensitizes cells to DNA damaging agents in a RAD51-independent manner

NARROW

Abstract 4305: Germline structural variants shape prostate cancer clinical and molecular evolution

Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors

Abstract SY37-01: Genomic instability and hypoxia as co-drivers of prostate cancer aggression

Abstract 3810: Persistence of smoking signature 4 in the non-small cell lung cancer genome

Abstract 1763: Tumor mutational burden, mutational signatures and copy number variation in lung cancer driven by the Ras-Raf-MEK-ERK pathway

Abstract B100: High-risk pathologic and genomic features of BRCA2-mutant prostate cancer

Abstract NG06: The clinico-genomics of localized, non-indolent prostate cancer: the CPC-GENE experience

Abstract 2432: The genomic consequences of tumor hypoxia in human cancers

Abstract 5860: Genomic architecture of prostate cancer at recurrence following radiotherapy

Abstract 98: The somatic mutational landscape of the mitochondrial genome in prostate cancer: evaluation of clinical impact

Abstract 745: Hybrid bioactive nanoparticles for modulating prostate tumor microenvironment and enhancing radiation therapy

Abstract 2214: Dynamic transcriptome analysis of DNA damage pathways under hypoxia

miRNA-95 Mediates Radioresistance in Tumors by Targeting the Sphingolipid Phosphatase SGPP1

Imatinib Radiosensitizes Bladder Cancer by Targeting Homologous Recombination

Abstract 3184: Whole genome sequencing of low-input fresh frozen prostate cancer biopsies

Abstract 3916: PML nuclear bodies are juxtaposed to DNA-DSBs following IR-induced DNA damage

Tumor Cell Kill by c-MYC Depletion: Role of MYC-Regulated Genes that Control DNA Double-Strand Break Repair

Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment

MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer

Abstract 3932: Loss of PTEN sensitizes cells to DNA damaging agents in a RAD51-independent manner

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only